Newsletter Signup | Join Community
The checkpoint inhibitor Tecentiq (atezolizumab) improves the outcomes of treatment for bladder cancer.
Vicinium promising for treatment of early stage and superficial bladder cancers.
Everywhere we look in the media, we find claims that different diets can improve our quality of life.
Stay Current With Bladder Cancer Treatment Advances & Connect with Others
FDA Approves PD-1 Checkpoint Inhibitor Opdivo for Treatment of Bladder Cancer
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
IDO inhibitor epacadostat and the anti-PD-1 drug Keytruda (pembrolizumab) promising in bladder cancer.
Study reports that ~ 60% of patients with advanced bladder cancer respond to Votrient/Taxol chemotherapy
Doctors from MD Anderson report results of Balversa in advanced Urothelial cancer - Now FDA Approved
U.S. FDA Grants Fast Track Designation to GemRIS™ in Muscle Invasive Bladder Cancer
Intravesical Taxotere® Effective in Recurrent Superficial Bladder Cancer
Study from Sloan Kettering: Robot-assisted laparoscopic cystectomy takes longer to complete but has less blood loss
Taxotere® and Gemzar® is Effective for Treatment of Advanced Bladder Cancer
More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer
Some individuals are more genetically susceptible to this risk.
Hair Dye Linked to Bladder Cancer
Multi-Drug Chemo and Radiation Combo May Prolong Survival Time for Persons with Small-Cell Bladder Cancer
Radiation for Uterine Cancer May Increase Risk of Bladder Cancer
Death rate from bladder cancer continues to rise 20 years after exposure to high levels of arsenic in drinking water.
Learning about this often-overlooked cancer may save your life.
A Large Study Helps Define Outcomes for Patients with Superficial Bladder Cancer.
Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer
Uncertain Whether P53 Predicts Bladder Cancer Prognosis
Long-Term Survival with Aggressive Surgery in Advanced Bladder Cancer.
Improved Outcomes with Higher Volumes for Radical Cystectomy
New data suggest that the risk of bladder cancer among smokers may be higher than previous estimates.
Urine Test May Accurately Detect Bladder Cancer Recurrence
Long-term use of vitamin C, vitamin D, or vitamin E does not appear to reduce the risk of bladder cancer.
Components of Processed Meat May Increase Risk of Bladder Cancer
Radical Cystectomy is Effective Therapy for Selected Patients Age 70 Years or Older with Invasive Bladder Cancer
Study confirms experience of surgeon and hospital impacts treatment.
Delaying Cisplatin-Based Chemotherapy decreases survival in invasive bladder cancer when compared to immediate therapy
Neoadjuvant Chemotherapy Significantly Improves Survival in Bladder Cancer
A radical cystectomy, a surgery that involves removal of the bladder, is a common treatment for cancer of the bladder.
Immediate Adjuvant Chemotherapy Superior to Delayed for Treatment of Invasive Bladder Cancer
Some bladder cancers over express Her2. Herceptin® is being evaluated in for bladder cancer treatment
Michael O’Donnell, MD Director of Urologic Oncology, University of Iowa Hospitals and Clinics
Simple urine "dip stick" test may allow for early detection of bladder cancer and save lives.
Cancer Epidemiology, Biomarkers and Prevention: "risk of bladder cancer increases with duration and amount of smoking."
Stanford researchers report patients experience good quality of life after cystectomy for bladder cancer.
Diabetes Drugs May Increase Risk of Bladder Cancer
Locally Advanced Small-Cell Bladder Cancer Responds to Aggressive Chemo/Radiation Combo
Study suggests that Robotic-assisted radical cystectomy (RARC) may reduce blood loss and shorten length of stay
Could one strain of BCG for Bladder Cancer be better than the other?
Researchers from the Universities of Rochester and Wisconsin studied the impact of bladder cancer screen in men
Exposure to Aromatic Amines Poses Long-term Risk of Bladder Cancer
Female Smokers Have Higher Risk of Bladder Cancer Than Male Smokers
Study confirms benefit of Taxol/Gemzar combination
Bladder preserving surgery in bladder cancer.
BLCA-4 Urine Test May Allow Earlier Detection of Bladder Cancer
Children?s Exposure to Second-hand Smoke Increases Risk of Bladder Cancer
Gemzar® and Eloxatin® Promising for Advanced Bladder Cancer.
Genetic Mutations Associated with One-Third of Bladder Cancer
Neoadjuvant Chemotherapy Improves Survival for Bladder Cancer
Molecular Technique May Improve Detection of Bladder Cancer Recurrences
Chemotherapy Plus Radiation Increase Bladder Preservation and Quality of Life in Locally Advanced Bladder Cancer.
Neoadjuvant Taxotere® and Platinol® Produces Favorable Outcomes in Patients with Bladder Cancer
Older Patients Fare Well After Xeloda® and Radiation Therapy for Bladder Cancer
Age Influences Response to Bladder Cancer Immunotherapy
MVAC Superior to DC in Advanced Bladder Cancer
Hexvix® Improves Detection of Early Bladder Cancer
Second-Opinion Pathology Discrepancies High for Bladder Cancer
Fluorescence Guiding Reduces Recurrences in Early Bladder Cancer
BCG/Mitomycin C Improves Outcomes Compared to BCG Alone in Stage I Bladder Cancer
Aggressive Surgical Treatment of Bladder Cancer Benefits Patients over the Age of 80
Addition of NMP22® BladderChek® Improves Detection of Recurrent Bladder Cancer
Patterns of Proteins in Urine Help Detect Bladder Cancer
Bacillus Calmette-Guérin (BCG) Immunotherapy is Superior to Mitomycin for Treatment of Superficial Bladder Cancer
P53 Mutation May Help Determine Prognosis for Bladder Cancer
DNA in Urine May Detect Bladder Cancer
Painters May Have Higher Risk of Bladder Cancer
?Marker? in Urine May Detect Bladder Cancer
Alfa Interferon Treatment for Patients with Superficial Bladder Cancer
Biomarkers for Bladder Cancer
FISH Testing from Urine Samples May Predict Risk of Cancer Progression in Patients with Superficial Bladder Cancer
Arsenic in Drinking Water Associated with Bladder Cancer
Some Chinese Herbs May Increase Risk of Urinary Tract Cancer
NMP22 Protein: A Marker for Bladder Cancer
Photodynamic Therapy, a Promising Treatment for Superficial Bladder Cancer
Adjuvant Chemotherapy May Improve Survival with Muscle-Invasive Bladder Cancer
Immunocyt” Enhances Detection of Bladder Cancer
Radical Cystectomy Improves Survival in Stage II Bladder Cancer
More Patients, Better Outcomes After Surgery for Urological Cancer
Markers Associated with Risk for Recurrence in Bladder Cancer
Gene-Based Test, UroVysion™, Approved to Aid in Diagnosis of Bladder Cancer
Less Toxic Adjuvant Chemotherapy Regimen for Patients with Locally Advanced Bladder Cancer Evaluated
Selenium May Have Protective Effect Against Bladder Cancer
Keynote 45 trial confirms Keytruda superior to chemotherapy for treatment of recurrent bladder (urothelial) cancer.
Durvalumab Granted Breakthrough Therapy Designation by US FDA for Treatment of Patients with PD-L1 Positive Urothelial
Chemotherapy after Surgery Appears to Improve Survival in Advanced Bladder Cancer
Gemzar® Is an Effective Drug for the Treatment of Advanced Bladder Cancer
Nutrition Report A Boost Against Bladder Cancer
Risk of Smoking-related Bladder Cancer Has Increased
Long-Term Follow-Up Suggests Chemotherapy Treatment Allows Bladder Function in Patients with Invasive Bladder Cancer
Radiation Therapy before Cystectomy Does Not Contribute To Improved Survival in Patients with Advanced Bladder Cancer
Can anyone share the experience with Keytruda? Any side effects?